Literature DB >> 8748804

The significance of neuron specific enolase levels in cerebrospinal fluid and serum after experimental traumatic brain damage.

M Uzan1, M Hanci, O Güzel, A C Sarioğlu, C Kuday, F Ozlen, M Y Kaynar.   

Abstract

In the posttraumatic period, measurement of neural tissue enzymes in serum and cerebrospinal fluid gives quantitative information about the severity of the head injury. In our study, we evaluated the relationship between the serum and cerebrospinal fluid levels of neuron specific enolase and the severity of trauma. Head traumas at different severity were applied experimentally (Mild 0.038 N, Moderate 0.057 N, Severe 0.3 N). Serum and cerebrospinal fluid levels of neuron specific enolase were measured in trauma and control groups of rats. Only in the severe trauma group, the neuron specific enolase levels of cerebrospinal fluid were significantly increased. There was no statistically significant difference between the groups when serum neuron specific enolase levels were evaluated. Our data leads us to conclude that trauma, causing significant neural damage, results in an increase in cerebrospinal fluid neuron specific enolase levels, however the serum neuron specific enolase levels do not seem to run parallel with that increase.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8748804     DOI: 10.1007/bf02187758

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  10 in total

1.  Neuron-specific enolase as a marker of neuronal lesions during various comas in man.

Authors:  H Scarna; B Delafosse; R Steinberg; G Debilly; B Mandrand; A Keller; J F Pujol
Journal:  Neurochem Int       Date:  1982       Impact factor: 3.921

2.  Levels of enolase and other enzymes in the cerebrospinal fluid as indices of pathological change.

Authors:  J A Royds; W R Timperley; C B Taylor
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-12       Impact factor: 10.154

3.  Pathophysiology of cerebrospinal fluid in head injury: Part 2. Biochemical markers for central nervous system trauma.

Authors:  R A Bakay; K M Sweeney; J H Wood
Journal:  Neurosurgery       Date:  1986-03       Impact factor: 4.654

4.  S-100 protein and neuron-specific enolase in CSF after experimental traumatic or focal ischemic brain damage.

Authors:  H G Hårdemark; N Ericsson; Z Kotwica; G Rundström; I Mendel-Hartvig; Y Olsson; S Påhlman; L Persson
Journal:  J Neurosurg       Date:  1989-11       Impact factor: 5.115

5.  Increased serum creatine kinase BB and neuron specific enolase following head injury indicates brain damage.

Authors:  I M Skogseid; H K Nordby; P Urdal; E Paus; F Lilleaas
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

6.  Enolase isoenzyme distribution in the human brain and its tumours.

Authors:  J A Royds; M A Parsons; C B Taylor; W R Timperley
Journal:  J Pathol       Date:  1982-05       Impact factor: 7.996

7.  Neuron-specific enolase is a marker of cerebral ischemia and infarct size in rat cerebrospinal fluid.

Authors:  H G Hårdemark; L Persson; H G Bolander; L Hillered; Y Olsson; S Påhlman
Journal:  Stroke       Date:  1988-09       Impact factor: 7.914

8.  Cerebrospinal fluid enolase in stroke.

Authors:  E Hay; J A Royds; G A Davies-Jones; N A Lewtas; W R Timperley; C B Taylor
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-07       Impact factor: 10.154

9.  High-dose glucocorticoid treatment improves neurological recovery in head-injured mice.

Authors:  E D Hall
Journal:  J Neurosurg       Date:  1985-06       Impact factor: 5.115

10.  Determination of brain 5-hydroxytryptamine turnover in freely moving rats using repeated sampling of cerebrovascular fluid.

Authors:  G S Sarna; P H Hutson; M D Tricklebank; G Curzon
Journal:  J Neurochem       Date:  1983-02       Impact factor: 5.372

  10 in total
  1 in total

1.  Biochemical changes in the injured brain.

Authors:  Seelora Sahu; Deb Sanjay Nag; Amlan Swain; Devi Prasad Samaddar
Journal:  World J Biol Chem       Date:  2017-02-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.